Coming back from ECCMID, one gets the impression that we are moving towards an era in which we can diagnose everything but treat nothing. A late breaker session on colistin resistance provided much detail data on the situation in the EU. As Continue reading The Brave New World of Infectious Diseases
A recent publication  from the team which brought us the Meningococcal B vaccine is of interest from the perspective of vaccine development strategy and feasibility. Link to this post!